Allarity completes stenoparib manufacturing campaign, gets key US patent and CLIA certificationAug 14Quarterly updateAllarity Therapeutics
NeOnc reports positive Phase 2a data for NEO100 in recurrent IDH1-mutant gliomaAug 12Regulatory decisionNeonc Technologies, Inc.perillyl alcohol
NeOnc confirms August 12 topline readout for Phase 2a NEO100 glioma studyAug 10Clinical readoutNEO212Neonc Technologies, Inc.
Black Diamond reports Phase 2 silevertinib data, plans FDA meeting on pivotal pathAug 5Quarterly updateBlack Diamond Therapeutics, Inc.silevertinib
Sign inSign in